Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3492 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Quest PharmaTech closes private placement

The company paid a 10% finder’s fee to a third party in connection with a portion of this private placement. The common shares were issued to qualified purchasers

Harden Healthcare acquires Girling Health Care

Harden Healthcare acquired two home health companies, Auxi Health and American HomeCare, earlier in 2007. With the addition of Girling, all home health operations will operate under the

Natus acquires Excel-Tech

Under the terms of the arrangement, Natus has acquired all of the outstanding common shares of Excel-Tech (Xltek) at a cash price of C$3.25 per share. The transaction

Barr receives FDA approval for generic Combunox

Oxycodone HCl and ibuprofen tablet is a generic version of Forest Pharmaceuticals’s Combunox. The approval came following the expiration of the new combination exclusivity period for Combunox. The

Opko Health acquires Ophthalmic Technologies

Rishard Weitz, president of Ophthalmic Technologies (OTI), said: “Opko has already made excellent progress in integrating OTI as we have actively worked together over the past months to

TPG Capital to acquire Axcan Pharma

The board of directors of Axcan has unanimously approved the agreement and recommends that shareholders vote to accept the offer. Under the terms of the transaction, TPG Capital